EXECUTIVE RETENTION AND SEPARATION AGREEMENTExecutive Retention and Separation Agreement • May 7th, 2020 • Moderna, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 7th, 2020 Company Industry JurisdictionThis Executive Retention Agreement (this “Agreement”) is entered into effective as of May 5, 2020 (the “Effective Date”) between Lorence Kim, M.D. (the “Executive”) and Moderna, Inc. (the “Company,” together with Executive, the “Parties”).